|
T8845 |
UTL-5g
|
3-Isoxazolecarboxamide, N-(2,4-dichlorophenyl)-5-methyl-,GBL-5g |
TNF
|
|
UTL-5g (3-Isoxazolecarboxamide, N-(2,4-dichlorophenyl)-5-methyl-) is a novel potential chemoprotective agent, TNF-α inhibitor that reduces cisplatin-induced side effects including nephrotoxicity, hepatotoxicity and hemat... |
|
T37538 |
Amifostine thiol
|
|
|
|
Amifostine thiol (WR-1065), the active metabolite of cytoprotector Amifostine, serves as a cytoprotective agent possessing radioprotective properties. It activates p53 via a JNK-dependent signaling pathway[1][2][3]. |
|
T12684 |
Radioprotectin-1
|
5-chloro-2-[4-(1,3-dioxobenzo[de]isoquinolin-2-yl)butylsulfamoyl]benzoic acid |
LPA Receptor
|
|
|
|
T6381 |
Amifostine trihydrate
|
Ethyol trihydrate,WR2721,Amifostine |
Others
,
HIF/HIF Prolyl-Hydroxylase
|
|
Amifostine trihydrate (WR2721) is the first approved radioprotective drug, used to decrease the risk of kidney problems caused by treatment with cisplatin. |
|
T29655 |
Adeturon
|
|
|
|
Adeturon can play radioprotective effect. |
|
T13862L |
Recilisib sodium
|
Brand name: Ex-RAD,ON 01210.Na,ON01210,ON-01210 |
|
|
Recilisib, also known as ON 01210.Na, is a radioprotectant, which modifys cell cycle distribution patterns in cancer cells subjected to radiation therapy, and it has been identified as a potential candidate for radiation... |
|
T78101 |
Zymosan A
|
Zymosan A from Saccharomyces cerevisiae |
|
|
Zymosan A, derived from Saccharomyces cerevisiae, is a TLR2 agonist and exhibits significant radioprotective effects, mitigating and preventing IR-induced intestinal injury in mice. Furthermore, Zymosan A aids in the reg... |
